Exactly, the only thing left is two board members from Menlo and the cash, nothing else and the down grades their company got was they were being priced @2 because they had all that cash, but had no products, deals, revenues, PDFUF ahead etc etc etc.
If one was to ever get into a biotech at the right time, and certainly and insanely right price its this one as was the other we were in when it was pushed to 1-2
You do not find them at this stage of the game facing the $$$ they are facing and having a market cap based just on their cash alone, that is like???????????
The numbers and info you can find on this company now which are based solely on Menlo Thera hell you may as well shake a cup of Yatzee dice and toss them and use those numbers, they bare no resemblance to reality. PT average $6.80 its never had a PT lower than $10 singularly let alone an average one.
Peace out.
News 
Market Data 
Discover 
